188 related articles for article (PubMed ID: 33129835)
1. Leukocyte-Mimetic Liposomes Penetrate Into Tumor Spheroids and Suppress Spheroid Growth by Encapsulated Doxorubicin.
Fukuta T; Yoshimi S; Kogure K
J Pharm Sci; 2021 Apr; 110(4):1701-1709. PubMed ID: 33129835
[TBL] [Abstract][Full Text] [Related]
2. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
Fukuta T; Kogure K
Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte-mimetic liposomes possessing leukocyte membrane proteins pass through inflamed endothelial cell layer by regulating intercellular junctions.
Fukuta T; Yoshimi S; Tanaka T; Kogure K
Int J Pharm; 2019 May; 563():314-323. PubMed ID: 30978483
[TBL] [Abstract][Full Text] [Related]
4. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
Fukuta T
Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
[TBL] [Abstract][Full Text] [Related]
5. Tumor Microenvironment-Sensitive Liposomes Penetrate Tumor Tissue via Attenuated Interaction of the Extracellular Matrix and Tumor Cells and Accompanying Actin Depolymerization.
Suzuki S; Itakura S; Matsui R; Nakayama K; Nishi T; Nishimoto A; Hama S; Kogure K
Biomacromolecules; 2017 Feb; 18(2):535-543. PubMed ID: 28055201
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-anchored macrophages hijack tumor microtube networks for selective drug transport and augmentation of antitumor effects in orthotopic lung cancer.
Guo L; Zhang Y; Wei R; Wang C; Feng M
Theranostics; 2019; 9(23):6936-6948. PubMed ID: 31660078
[No Abstract] [Full Text] [Related]
7. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
[TBL] [Abstract][Full Text] [Related]
8. Application of Coiled Coil Peptides in Liposomal Anticancer Drug Delivery Using a Zebrafish Xenograft Model.
Yang J; Shimada Y; Olsthoorn RC; Snaar-Jagalska BE; Spaink HP; Kros A
ACS Nano; 2016 Aug; 10(8):7428-35. PubMed ID: 27504667
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
[TBL] [Abstract][Full Text] [Related]
10. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
[TBL] [Abstract][Full Text] [Related]
11. Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes.
Chen IJ; Cheng YA; Ho KW; Lin WW; Cheng KW; Lu YC; Hsieh YC; Huang CC; Chuang CH; Chen FM; Su YC; Roffler SR; Cheng TL
Acta Biomater; 2020 Jul; 111():386-397. PubMed ID: 32417267
[TBL] [Abstract][Full Text] [Related]
12. Enhanced drug delivery using sonoactivatable liposomes with membrane-embedded porphyrins.
Wang X; Yan F; Liu X; Wang P; Shao S; Sun Y; Sheng Z; Liu Q; Lovell JF; Zheng H
J Control Release; 2018 Sep; 286():358-368. PubMed ID: 30075210
[TBL] [Abstract][Full Text] [Related]
13. Increased delivery of doxorubicin into tumor cells using extracellularly activated TAT functionalized liposomes: in vitro and in vivo study.
Yuan W; Kuai R; Ran R; Fu L; Yang Y; Qin Y; Liu Y; Tang J; Fu H; Zhang Q; Yuan M; Zhang Z; Gao F; He Q
J Biomed Nanotechnol; 2014 Aug; 10(8):1563-73. PubMed ID: 25016656
[TBL] [Abstract][Full Text] [Related]
14. Combined paclitaxel-doxorubicin liposomal results in positive prognosis with infiltrating lymphocytes in lung metastasis.
de Lima LI; Faria RS; Franco MS; Roque MC; Arruda Pacheco TJ; Rodrigues MC; Muehlmann LA; Moya SE; Azevedo RB; de Oliveira MC; Figueiró Longo JP
Nanomedicine (Lond); 2020 Dec; 15(28):2753-2770. PubMed ID: 33179587
[No Abstract] [Full Text] [Related]
15. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.
Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of cholesteryl doxorubicin and its anti-cancer activity.
Choi JS; Doh KO; Kim BK; Seu YB
Bioorg Med Chem Lett; 2017 Feb; 27(4):723-728. PubMed ID: 28129977
[TBL] [Abstract][Full Text] [Related]
18. Binding and interstitial penetration of liposomes within avascular tumor spheroids.
Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud A; Sgouros G
Int J Cancer; 2004 Nov; 112(4):713-21. PubMed ID: 15382056
[TBL] [Abstract][Full Text] [Related]
19. Application of liposomes incorporating doxorubicin with sialyl Lewis X to prevent stenosis after rat carotid artery injury.
Tsuruta W; Tsurushima H; Yamamoto T; Suzuki K; Yamazaki N; Matsumura A
Biomaterials; 2009 Jan; 30(1):118-25. PubMed ID: 18842296
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
Yuan M; Qiu Y; Zhang L; Gao H; He Q
Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
